
Stock Details
CEO
Todd Usen
Sector
Healthcare
Industry
Medical - Devices
Full Time Employees
80
Address
26051 Merit Circle, Laguna Hills, DE, 92653
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Top Competitors
Income Statement
Financials
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Adagio Medical Holdings, Inc. $1.29
$0
$249.61
$325
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results